ProPhase Labs, Inc. is a diversified biotech, genomics, and consumer products company. It offers whole genome sequencing through Nebula Genomics and DNA Complete, develops novel drugs and dietary supplements via ProPhase BioPharma (PBIO), markets TK Supplements dietary supplements, and previously provided COVID-19 PCR and antigen diagnostic testing. The company also owns worldwide exclusive rights to the BE-Smart Esophageal Pre-Cancer diagnostic screening test.
Q2 FY2026 — expected 2026-09-19
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-04-01 | 2024-12-31 | 0000868278-25-000003 | EDGAR | 73K words |
| 2024-03-29 | 2023-12-31 | 0000868278-24-000004 | EDGAR | — |
| 2023-03-29 | 2022-12-31 | 0000868278-23-000004 | EDGAR | — |
| 2022-03-31 | 2021-12-31 | 0001493152-22-008541 | EDGAR | — |
| 2021-03-31 | 2020-12-31 | 0001493152-21-007538 | EDGAR | — |
| 2020-03-26 | 2019-12-31 | 0001493152-20-004807 | EDGAR | — |
| 2019-03-26 | 2018-12-31 | 0001493152-19-003946 | EDGAR | — |
| 2018-03-28 | 2017-12-31 | 0001493152-18-004041 | EDGAR | — |
| 2017-02-24 | 2016-12-31 | 0001493152-17-001890 | EDGAR | — |
| 2016-03-29 | 2015-12-31 | 0001493152-16-008343 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-19 | 2025-09-30 | 0000868278-25-000017 | EDGAR | 34K words |
| 2025-08-13 | 2025-06-30 | 0000868278-25-000011 | EDGAR | — |
| 2025-05-20 | 2025-03-31 | 0000868278-25-000007 | EDGAR | — |
| 2024-11-13 | 2024-09-30 | 0000868278-24-000014 | EDGAR | — |
| 2024-08-14 | 2024-06-30 | 0000868278-24-000010 | EDGAR | — |
| 2024-05-10 | 2024-03-31 | 0000868278-24-000007 | EDGAR | — |
| 2023-11-13 | 2023-09-30 | 0000868278-23-000017 | EDGAR | — |
| 2023-08-11 | 2023-06-30 | 0000868278-23-000014 | EDGAR | — |
| 2023-05-12 | 2023-03-31 | 0000868278-23-000008 | EDGAR | — |
| 2022-11-10 | 2022-09-30 | 0001493152-22-031384 | EDGAR | — |
| 2022-08-12 | 2022-06-30 | 0001493152-22-022350 | EDGAR | — |
| 2022-05-13 | 2022-03-31 | 0001493152-22-013346 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-02-13 | 0001493152-26-006784 | EDGAR | 1K words |
| 2026-02-13 | 0001493152-26-006785 | EDGAR | — |
| 2026-01-27 | 0001493152-26-003724 | EDGAR | — |
| 2026-01-23 | 0001493152-26-003460 | EDGAR | — |
| 2026-01-23 | 0001493152-26-003456 | EDGAR | — |
| 2026-01-09 | 0001493152-26-001143 | EDGAR | — |
| 2026-01-09 | 0001493152-26-001134 | EDGAR | — |
| 2026-01-02 | 0001493152-26-000175 | EDGAR | — |
| 2025-12-19 | 0001493152-25-028537 | EDGAR | — |
| 2025-12-19 | 0001493152-25-028483 | EDGAR | — |
471 total filings indexed. 439 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000868278 |
| Ticker | PRPH |
| Exchange | OTC |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Headquarters | Old Bridge, New Jersey |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report